Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07671976 · ClinicalTrials.gov registry record · NA
Applying the Intention-Action Framework to Specialty Referrals
A NA study, sponsored by University of California, Los Angeles.
- Not yet
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
NCT07671976: Clinical Trial NA study, sponsored by University of California, Los Angeles.
NCT07671976 is a NA study that has not yet begun recruiting, run by University of California, Los Angeles. The registered enrollment target is 1,600 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07671976, a NA study, has not yet begun recruiting, sponsored by University of California, Los Angeles.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
This is a prospective randomized controlled trial evaluating an EHR-embedded behavioral intervention intended to reduce low-value specialty referrals in cardiology, pulmonology, and gastroenterology. The intervention is designed to (1) strengthen physicians' intentions to avoid low-value specialty referrals at the point of encounter by presenting criteria for high-value referrals and informing physicians that referral decisions may be reviewed and (2) support follow-through on these intentions by modifying the referral process through structured checklist prompts embedded within the referral workflow. The primary hypothesis is that physicians exposed to the intervention will demonstrate lower rates of low-value cardiology, pulmonology, and gastroenterology referrals compared with physicians exposed to the arm where the order composer allows physicians to place referrals with minimal decision support.
Primary Outcome
A low-value referral is defined as a referral to one of the three target specialty divisions placed during a referral-relevant encounter that does not meet the pre-specified referral criteria developed by UCLA Health division chiefs for the corresponding medical condition. The primary outcome is calculated as the number of low-value referrals divided by the number of referral-relevant encounters, multiplied by 100, aggregated at the physician level.
Interventions
- BEHAVIORAL Checklist
- BEHAVIORAL Information provision
- BEHAVIORAL Auditing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What is known before NCT07671976 opens enrollment
NCT07671976 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 3 interventions - of which Checklist is the first listed.
NCT07671976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07671976 about?
NCT07671976 is a clinical study titled "Applying the Intention-Action Framework to Specialty Referrals". This is a prospective randomized controlled trial evaluating an EHR-embedded behavioral intervention intended to reduce low-value specialty referrals in cardiology, pulmonology, and gastroenterology. The intervention is designed to (1) strengthen physicians' intentions to avoid low-value specialty r...
What is the current status of trial NCT07671976?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,600 participants. The study started on 2026-07-01. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07671976?
The interventions under investigation include: Checklist (BEHAVIORAL), Information provision (BEHAVIORAL), Auditing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07671976?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07671976's enrollment target sits among peer trials
1,600 63rd of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI